CD274 and gastric cancer: A review of PD-L1 expression in gastric cancer (Vrna et al., 2018) showed that the percentage of PD-L1+ in the TCs ranges from 9% to 49.1% (most of the trials were performed in Asian populations), similar to our results (41.2% in TCs).